Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure helps cut through all the noise.
Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.
The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate. The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction.
The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to look at a qualifying stock. Thermo Fisher Scientific (TMO) holds a Zacks Rank #3 at the moment and its Most Accurate Estimate comes in at $5.96 a share nine days away from its upcoming earnings release on January 30, 2025.
TMO has an Earnings ESP figure of 0.65%, which, as explained above, is calculated by taking the percentage difference between the $5.96 Most Accurate Estimate and the Zacks Consensus Estimate of $5.92.
TMO is one of just a large database of Medical stocks with positive ESPs. Another solid-looking stock is Illumina (ILMN).
Illumina is a Zacks Rank #3 (Hold) stock, and is getting ready to report earnings on February 6, 2025. ILMN's Most Accurate Estimate sits at $0.92 a share 16 days from its next earnings release.
The Zacks Consensus Estimate for Illumina is $0.90, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of 1.94%.
TMO and ILMN's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.
Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
Illumina, Inc. (ILMN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.